Related Experiment Videos
Increase in urinary beta-phenylethylamine preceding the switch from mania to depression: a "rapid cycler"
J Semba1, M Nankai, Y Maruyama
1Department of Neuropsychiatry, Faculty of Medicine, Tokyo Medical and Dental University, Japan.
The Journal of Nervous and Mental Disease
|February 1, 1988
Summary
beta-Phenylethylamine (PEA) may trigger mood shifts in rapid cyclers. Modulating PEA metabolism with carbidopa or safrazine did not prevent mood cycling in a case study.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- beta-Phenylethylamine (PEA), an endogenous amphetamine-like substance, influences central catecholamine metabolism.
- PEA has been hypothesized to play a role in the etiology of affective disorders.
Observation:
- A rapid cycler exhibited increased PEA excretion preceding a shift from mania to depression.
- The study investigated modulating PEA metabolism to prevent mood cycle switches.
Findings:
- Carbidopa administration decreased PEA excretion but worsened manic symptoms.
- Safrazine increased PEA levels without improving depressive symptoms.
Implications:
- These results suggest beta-Phenylethylamine (PEA) may act as a biochemical trigger in the mood switching mechanism of rapid cyclers.
- PEA's role, particularly in the mania-to-depression transition, warrants further investigation in bipolar disorder research.